Trials / Completed
CompletedNCT03926286
Fecal Microbial Transplant (FMT) for Sjogrens Syndrome
Fecal Microbial Transplant for Sjogrens Syndrome
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- University of Miami · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is an open label study to evaluate the effect of Fecal Microbiota Transplantation (FMT) on the gut microbiome and Systemic parameters.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | FMP-30 | FMP-30 containing frozen human fecal microbiota administered as (3) units of FMP30 enema on Day 0 and Week1 |
Timeline
- Start date
- 2019-04-15
- Primary completion
- 2020-06-01
- Completion
- 2020-06-01
- First posted
- 2019-04-24
- Last updated
- 2020-06-05
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03926286. Inclusion in this directory is not an endorsement.